Head-to-head comparisons
Editorial comparisons of the most-asked-about peptide matchups, with a clear breakdown of how they differ and a goal-oriented verdict. Each links to both full profiles with primary-source citations.
Semaglutide vs Tirzepatide
Both are once-weekly incretin therapies for weight and glycemic management. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a dual GIP and GLP-1 receptor agonist.
Read the comparisonBPC-157 vs TB-500
Two of the most-discussed recovery peptides. They are often stacked rather than chosen against each other, and neither is FDA-approved; human evidence is limited for both.
Read the comparisonCJC-1295 vs Ipamorelin
Two growth-hormone-axis peptides that are usually combined rather than compared. CJC-1295 is a GHRH analog; ipamorelin is a selective ghrelin/GHS-R agonist.
Read the comparisonNot medical advice
Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.